Live talk, session 12 – August 4, 2022: Residual and recurring Cushing’s

August 5, 2022

It’s always fascinating to listen to two of the recognized experts and leading clinicians in Cushing’s disease discuss their experiences with the disease and patients.  In this Live Talk session, Pituitary World New’s innovative program for education and awareness, Dr. Kevin Yuen and Dr. Lewis Blevins bring an intimate, revealing look at their approaches to Cushing’s disease and syndrome.  The discussion focuses on their experiences and how they think about their patients, and the options they have available for treatment.  Listen and learn their views on each available drug to treat the disease and their rationale for recommending treatment options.  And don’t miss the discussion on access to those medications, including insurance coverage issues, towards the end of the session.  Enjoy!

Positive news for new Cushing’s drug

September 23, 2019

In a press release, Strongbridge Biopharma announced comprehensive positive results of their Phase 3 SONICS study of RECORLEVTM (levoketoconazole) for the potential treatment of endogenous Cushing’s syndrome. The results were published online in The Lancet

A review of drugs for tumors that produce ACTH

July 16, 2019

In this podcast, Dr. Blevins reviews a study conducted at the Ludwig Maximilian University of Munich, Germany on pituitary tumor therapeutics and the treatment for tumors that produce ACTH and cause Cushing’s.  Dr. Blevins reviews

The incidence of Cushing’s

June 3, 2019

In this podcast, we discuss the latest data on the incidence of Cushing’s disease worldwide based on a recent Swedish study on the subject, and the importance of disease awareness in early diagnosis.